I’ll be there too. Lachlan
From: cyclinggroupbasel-bounce@xxxxxxxxxxxxx
[mailto:cyclinggroupbasel-bounce@xxxxxxxxxxxxx] On Behalf Of Talbot, Darren
Sent: Tuesday, April 18, 2017 3:15 PM
To: cyclinggroupbasel@xxxxxxxxxxxxx
Subject: [cyclinggroupbasel] Re: Today's Ride
Deal me in for tonight
On 18 April 2017 at 15:03, Kristof Kowalski
<kristof@xxxxxxxxxxx<mailto:kristof@xxxxxxxxxxx>> wrote:
Cool bananas.
I’ll be down for a spin as well, so will pop down to the usual meeting place at
6PM.
😊
--
Kristof Kowalski
kristof@xxxxxxxxxxx<mailto:kristof@xxxxxxxxxxx> // @krzko
From:
cyclinggroupbasel-bounce@xxxxxxxxxxxxx<mailto:cyclinggroupbasel-bounce@xxxxxxxxxxxxx>
[mailto:cyclinggroupbasel-bounce@xxxxxxxxxxxxx<mailto:cyclinggroupbasel-bounce@xxxxxxxxxxxxx>]
On Behalf Of McAulay, Gavin
Sent: Tuesday, April 18, 2017 3:00 PM
To: cyclinggroupbasel@xxxxxxxxxxxxx<mailto:cyclinggroupbasel@xxxxxxxxxxxxx>
Subject: [cyclinggroupbasel] Re: Today's Ride
Hi Kristof
I'm planning to ride, I think Darren can make it as well
Gav
Gavin McAulay
Senior Strategic Insights Manager: Neuroscience & Rare Diseases
F. Hoffmann-La Roche Ltd.
Pharmaceutical Division GPS
Building 1/OG12.S663
Grenzacherstrasse 124
CH-4070 Basel
Tel:+41 61 687 20 67
Confidentiality Note: This message is intended only for the use of the named
recipient(s) and may contain confidential and/or privileged information. If you
are not the intended recipient, please contact the sender and delete this
message. Any unauthorized use of the information contained in this message is
prohibited.
On Tue, Apr 18, 2017 at 2:51 PM, Kristof Kowalski
<kristof@xxxxxxxxxxx<mailto:kristof@xxxxxxxxxxx>> wrote:
Hey all,
Haven’t seen an email go out about today’s ride. Is one going ahead today?
Cheers,
--
Kristof Kowalski
kristof@xxxxxxxxxxx<mailto:kristof@xxxxxxxxxxx> // @krzko
--
Darren Talbot. PhD
Senior Portfolio Planning & Decision Analysis Leader
Roche Pharma Research and Early Development
Strategy & Portfolio
Roche Innovation Center Basel
Mob: +41 791040310. Tel: +41 61 688 8961
Confidentiality Note: This message is intended only for the use of the named
recipient(s) and may contain confidential and/or proprietary information. If
you are not the intended recipient, please contact the sender and delete this
message. Any unauthorized use of the information contained in this message is
prohibited.
